Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMONO for Peripheral Neuropathic Pain
2015-004779-64Phase 2Completed
- Sponsor
- Air Liquide
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Peripheral neuropathic pain and Neuralgia comparing EMONO (nitrous oxide + oxygen) with Placebo synthetic medical air (2 arms). Primary endpoint: Change in mean pain intensity. Started Jul 2016; status: completed.
02
Drugs
nitrous oxide
03
Conditions
Peripheral neuropathic painNeuralgia
Beyond the preview
Go deeper on 2015-004779-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004779-64.